Celldex Therapeutics, Inc. Accrued Liabilities, Current
Celldex Therapeutics, Inc. (CLDX) had Accrued Liabilities, Current of $43.86 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Accrued Liabilities, Current $43.86M.
- 2026-03-31: Accrued Liabilities, Current $38.42M.
- 2025-12-31: Accrued Liabilities, Current $47.03M.
- 2025-09-30: Accrued Liabilities, Current $39.72M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2026-06-30 | $43.86M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $38.42M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $47.03M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $39.72M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $28.42M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $25.46M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $33.84M 10-K · filed 2026-02-25 |
| 2024-09-30 | $28.20M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $18.59M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $17.54M 10-Q · filed 2024-05-06 |
| 2023-12-31 | $22.03M 10-K · filed 2025-02-27 |
| 2023-09-30 | $18.47M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $12.26M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $9.37M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $12.84M 10-K · filed 2024-02-26 |
| 2022-09-30 | $11.43M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $11.23M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $9.23M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $12.00M 10-K · filed 2023-02-28 |
| 2021-09-30 | $10.25M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $7.85M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $7.02M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $8.46M 10-K · filed 2022-02-28 |
| 2020-09-30 | $8.01M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $6.47M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $5.65M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $6.50M 10-K · filed 2021-03-29 |
| 2019-09-30 | $6.42M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $5.41M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $5.47M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $7.01M 10-K · filed 2020-03-26 |
| 2018-09-30 | $9.61M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $12.26M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $14.90M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $19.45M 10-K · filed 2019-03-07 |
| 2017-09-30 | $17.84M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $21.27M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $19.42M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $28.66M 10-K · filed 2018-03-07 |
| 2016-09-30 | $13.23M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $14.94M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $18.43M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $24.32M 10-K · filed 2017-03-14 |
| 2015-09-30 | $19.62M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $21.88M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $15.42M 10-Q · filed 2015-04-29 |
| 2014-12-31 | $19.30M 10-K/A · filed 2016-02-25 |
| 2014-09-30 | $17.70M 10-Q · filed 2014-11-05 |
| 2014-06-30 | $17.90M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $14.97M 10-Q · filed 2014-05-01 |
| 2013-12-31 | $17.18M 10-K · filed 2015-02-24 |
| 2013-09-30 | $13.81M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $9.90M 10-Q · filed 2013-08-06 |
| 2013-03-31 | $9.69M 10-Q · filed 2013-05-03 |
| 2012-12-31 | $10.96M 10-K · filed 2014-03-03 |
| 2012-09-30 | $8.16M 10-Q · filed 2012-11-02 |
| 2012-06-30 | $6.55M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $6.36M 10-Q · filed 2012-05-04 |
| 2011-12-31 | $7.01M 10-K · filed 2013-03-08 |
| 2011-09-30 | $5.97M 10-Q · filed 2011-11-03 |
| 2011-06-30 | $4.42M 10-Q · filed 2011-08-04 |
| 2010-12-31 | $4.94M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |